Saccharin and cyclamate inhibit binding of epidermal growth factor.
about
Assessment of the carcinogenicity of the nonnutritive sweetener cyclamate.Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts.Toxicological aspects of cyclamate and cyclohexylamine.Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process.Properties of a monoclonal antibody to epidermal growth factor receptor with implications for the mechanism of action of EGFHigh affinity epidermal growth factor receptors on the surface of A431 cells have restricted lateral diffusion.
P2860
Saccharin and cyclamate inhibit binding of epidermal growth factor.
description
1981 nî lūn-bûn
@nan
1981 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@ast
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@en
type
label
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@ast
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@en
prefLabel
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@ast
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@en
P2860
P356
P1476
Saccharin and cyclamate inhibit binding of epidermal growth factor.
@en
P2093
P2860
P304
P356
10.1073/PNAS.78.2.1042
P407
P577
1981-02-01T00:00:00Z